androgen receptor downregulator AZD3514
Term · Oncology and biomedicine · MLC-T-ONC-010076
An orally available selective androgen receptor (AR) downregulator (SARD), with potential antineoplastic activity. Upon oral administration, AZD3514 binds to the AR ligand binding domain and inhibits the binding of androgen, thereby preventing androgen-dependent AR signaling. AZD3514 also causes downregulation of AR expression, which further prevents AR-mediated signaling. This results in an inhibition of proliferation in AR-overexpressing tumor cells. AR plays a key role in the proliferation of castration-resistant prostate cancer cells.
| Identifier | MLC-T-ONC-010076 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | SARD AZD3514 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010076",
"term": "androgen receptor downregulator AZD3514",
"field": "Oncology and biomedicine",
"definition": "An orally available selective androgen receptor (AR) downregulator (SARD), with potential antineoplastic activity. Upon oral administration, AZD3514 binds to the AR ligand binding domain and inhibits the binding of androgen, thereby preventing androgen-dependent AR signaling. AZD3514 also causes downregulation of AR expression, which further prevents AR-mediated signaling. This results in an inhibition of proliferation in AR-overexpressing tumor cells. AR plays a key role in the proliferation of castration-resistant prostate cancer cells.",
"synonyms": [
"SARD AZD3514"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/androgen-receptor-downregulator-azd3514/"
}
Record 1,085 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.